Medication Development in Alcoholism: Investigating PPAR Agonists
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The primary hypotheses under test are that alcohol dependent subjects treated with
fenofibrate will report decreased craving for alcohol following cue-exposure in the
laboratory and report less drinking post treatment relative to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
The Scripps Research Institute
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)